AQUESTIVE THERAPEUTICS INC (AQST) Institutional Ownership
None of the superinvestors we track currently report AQUESTIVE THERAPEUTICS INC (AQST) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in AQUESTIVE THERAPEUTICS INC (AQST), this page will show disclosed ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 1 | $2,677,024 | 414,400 |
| Q3 2025 | 1 | $486,330 | 87,000 |
| Q4 2024 | 1 | $339,624 | 95,400 |
| Q3 2024 | 1 | $142,428 | 28,600 |
| Q2 2024 | 1 | $1,290,120 | 496,200 |
| Q1 2024 | 1 | $5,861 | 1,375,800 |
| Q4 2023 | 1 | $2,568 | 1,271,500 |
| Q3 2023 | 1 | $1,728 | 1,129,189 |
| Q2 2023 | 1 | $2,030 | 1,230,196 |
| Q1 2023 | 1 | $591 | 518,800 |
| Q4 2022 | 1 | $417 | 462,737 |
| Q3 2022 | 1 | $1,054 | 900,800 |
Related AQST Institutional Insights:
- AQST Institutional Ownership & Insiders Activity
- AQST Institutional Ownership & 13F Activity
- AQST Top Institutional Shareholders
- AQST Institutional Buying Activity
- AQST Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- AQST Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings